| Citation Matrix | Glossary HistCite Guide |
| Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RCT, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR NATURE MEDICINE 8 (1): 68-74 JAN 2002 and the citing papers |
Nodes: 170,
Authors: 698,
Sources: 101,
Outer References: 6059
Collection span: 2002 - 2004
LCSb: 52 (30.59%) nodes before 2003
(1 years)
LCSe: 118 (69.41%) nodes after 2002
(2 years)
View: Bibliometric. Sorted by NCR.
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 299 | 103 2003 FRONTIERS IN BIOSCIENCE 8():D156-D175
Evens AM; Gartenhaus RB Molecular etiology of mature T-cell Non-Hodgkins lymphomas | 0 | 0.00 | 0 | 0.00 | 0 | |
| 2 | 1 | 268 | 1 2002 ADVANCES IN CANCER RESEARCH, VOL 86 86():149-193
Castelli C; Maeurer MJ The T-Cell response in patients with cancer | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 3 | 4 | 198 | 113 2003 IMMUNOLOGICAL REVIEWS 194(1):140-163
Shaughnessy JD; Barlogie B Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling | 0 | 0.00 | 1 | 0.50 | 0 | |
| 4 | 2 | 166 | 147 2003 NATURE REVIEWS DRUG DISCOVERY 2(7):566-580
Frank R; Hargreaves R Clinical biomarkers in drug discovery and development | 0 | 0.00 | 1 | 0.50 | 0 | |
| 5 | 1 | 150 | 19 2002 CURRENT OPINION IN ONCOLOGY 14(5):490-503
Ravi R; Bedi A Potential methods to circumvent blocks in apoptosis in lymphomas | 0 | 0.00 | 2 | 0.67 | 0 | 0 |
| 6 | 2 | 150 | 146 2003 NATURE REVIEWS DRUG DISCOVERY 2(4):296-313
Dancey J; Sausville EA Issues and progress with protein kinase inhibitors for cancer treatment | 0 | 0.00 | 15 | 7.50 | 0 | |
| 7 | 1 | 149 | 24 2002 HISTOPATHOLOGY 41(6):482-509
Pileri SA; Dirnhofer S; Went P; Ascani S; Sabattini E; Marafioti T; Tzankov A; Leoncini L; Faliniu B; Zinzani PL Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification | 1 | 0.33 | 2 | 0.67 | 0 | 1 |
| 8 | 1 | 147 | 12 2002 CLINICAL IMMUNOLOGY 103(3):217-230
French SW; Dawson DW; Miner MD; Doerr JR; Malone CS; Wall R; Teitell MA DNA methylation profiling: A new tool for evaluating hematologic malignancies | 0 | 0.00 | 3 | 1.00 | 0 | 0 |
| 9 | 1 | 142 | 39 2002 NATURE REVIEWS CANCER 2(3):231-238
Little MT; Storb R History of haematopoietic stem-cell transplantation | 0 | 0.00 | 5 | 1.67 | 0 | 0 |
| 10 | 1 | 123 | 153 2003 ONCOGENE 22(42):6497-6507
Russo G; Zegar C; Giordano A Advantages and limitations of microarray technology in human cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 11 | 1 | 120 | 40 2002 NATURE REVIEWS IMMUNOLOGY 2(12):920-932
Shaffer AL; Rosenwald A; Staudt LM Lymphoid malignancies: The dark side of B-cell differentiation | 1 | 0.33 | 10 | 3.33 | 0 | 1 |
| 12 | 3 | 115 | 23 2002 EXPERT OPINION ON THERAPEUTIC PATENTS 12(12):1783-1794
Cullen P; Lorkowski S DNA micro-arrays in medicine: manufacturing techniques and potential applications | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 13 | 1 | 103 | 134 2003 LEUKEMIA 17(10):1948-1960
Fisher RI; Shah P Current trends in large cell lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 14 | 1 | 103 | 145 2003 NATURE REVIEWS CANCER 3(12):895-902
Pardal R; Clarke MF; Morrison SJ Applying the principles of stem-cell biology to cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 15 | 1 | 100 | 28 2002 KIDNEY INTERNATIONAL 62(4):1125-1135
Eikmans M; Baelde HJ; De Heer E; Bruijn JA RNA expression profiling as prognostic tool in renal patients: Toward nephrogenomics | 0 | 0.00 | 5 | 1.67 | 0 | 0 |
| 16 | 2 | 98 | 34 2002 NATURE GENETICS 32():502-508
Slonim DK From patterns to pathways: gene expression data analysis comes of age | 4 | 1.33 | 39 | 13.00 | 2 | 2 |
| 17 | 1 | 96 | 98 2003 CURRENT OPINION IN ONCOLOGY 15(1):36-43
Guo QM DNA microarray and cancer | 0 | 0.00 | 2 | 1.00 | 0 | |
| 18 | 2 | 96 | 169 2004 EXPERT OPINION ON BIOLOGICAL THERAPY 4(1):83-93
Espina V; Dettloff KA; Cowherd S; Petricoin EF; Lotta LA Use of proteomic analysis to monitor responses to biological therapies | 0 | 0.00 | 0 | 0.00 | 0 | |
| 19 | 1 | 95 | 163 2003 SEMINARS IN ONCOLOGY 30(4):465-475
Dechant M; Bruenke J; Valerius T HLA class II antibodies in the treatment of hematologic malignancies | 0 | 0.00 | 0 | 0.00 | 0 | |
| 20 | 1 | 94 | 58 2003 ANNALS OF HEMATOLOGY 82(11):661-670
Maartense E; Kluin-Nelemans HC; Noordijk EM Non-Hodgkin's lymphoma in the elderly - A review with emphasis on elderly patients, geriatric assessment, and future perspectives | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 21 | 3 | 94 | 115 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 77(3):213-225
Shaughnessy JD Global gene expression profiling in the study of multiple myeloma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 22 | 1 | 87 | 22 2002 ENDOCRINOLOGY 143(6):1983-1989
Afshari CA Perspective: Microarray technology, seeing more than spots | 1 | 0.33 | 7 | 2.33 | 1 | 0 |
| 23 | 1 | 86 | 154 2003 ONCOLOGY RESEARCH 13(6-10):323-331
Li XY; Lim B RhoGTPases and their role in cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 24 | 1 | 85 | 131 2003 LANCET ONCOLOGY 4(3):177-185
Lonning PE Study of suboptimum treatment response: lessons from breast cancer | 0 | 0.00 | 2 | 1.00 | 0 | |
| 25 | 1 | 84 | 136 2003 MAYO CLINIC PROCEEDINGS 78(3):307-317
Ansell SM; Ackerman MJ; Black JL; Roberts LR; Tefferi A Primer on medical Genomics part VI: Genomics and molecular genetics in clinical practice | 0 | 0.00 | 0 | 0.00 | 0 | |
| 26 | 1 | 80 | 111 2003 HUMAN PATHOLOGY 34(4):352-358
Bagg A Clinical applications of molecular genetic testing in hematologic malignancies: Advantages and limitations | 0 | 0.00 | 0 | 0.00 | 0 | |
| 27 | 3 | 80 | 161 2003 SEMINARS IN HEMATOLOGY 40(4):296-307
Wiestner A; Staudt LM Towards molecular diagnosis and targeted therapy of lymphoid malignancies | 0 | 0.00 | 0 | 0.00 | 0 | |
| 28 | 2 | 78 | 47 2002 PHARMACOGENOMICS 3(5):589-601
Chicurel ME; Dalma-Weiszhausz DD Microarrays in pharmacogenomics - advances and future promise | 0 | 0.00 | 6 | 2.00 | 0 | 0 |
| 29 | 1 | 77 | 77 2003 BLOOD 102(12):3871-3879
Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; de Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RCT; Li SG; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 30 | 2 | 76 | 112 2003 IMMUNOLOGICAL REVIEWS 193(1):93-100
Ruland J; Mak TW Transducing signals from antigen receptors to nuclear factor kappa B | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 31 | 5 | 75 | 164 2003 TISSUE ANTIGENS 62(2):93-103
Boussioutas A; Haviv I Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines | 0 | 0.00 | 0 | 0.00 | 0 | |
| 32 | 2 | 73 | 33 2002 NATURE GENETICS 32():481-489
Holloway AJ; van Laar RK; Tothill RW; Bowtell DDL Options available - from start to finish - for obtaining data from DNA microarrays | 1 | 0.33 | 23 | 7.67 | 0 | 1 |
| 33 | 1 | 70 | 150 2003 ONCOGENE 22(15):2361-2373
Mischel PS; Shai R; Shi T; Horvath S; Lu KV; Choe G; Seligson D; Kremen TJ; Palotie A; Liau LM; Cloughesy TF; Nelson SF Identification of molecular subtypes of glioblastoma by gene expression profiling | 1 | 0.50 | 2 | 1.00 | 1 | |
| 34 | 1 | 69 | 117 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(8):5794-5801
Podar K; Tai YT; Cole CE; Hideshima T; Sattler M; Hamblin A; Mitsiades N; Schlossman RL; Davies FE; Morgan GJ; Munshi NC; Chauhan D; Anderson KC Essential role of caveolae in interleukin-6-and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells | 0 | 0.00 | 9 | 4.50 | 0 | |
| 35 | 2 | 69 | 130 2003 LABORATORY INVESTIGATION 83(3):305-316
Bertucci F; Viens P; Tagett R; Nguyen C; Houlgatte R; Birnbaum D DNA arrays in clinical oncology: Promises and challenges | 0 | 0.00 | 1 | 0.50 | 0 | |
| 36 | 2 | 69 | 162 2003 SEMINARS IN IMMUNOLOGY 15(3):177-183
Ruland J; Mak TW From antigen to activation: specific signal transduction pathways linking antigen receptors to NF-kappa B | 0 | 0.00 | 0 | 0.00 | 0 | |
| 37 | 3 | 69 | 167 2004 BLOOD 103(1):275-282
Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Delabie J; Ott G; Muller-Hermelink HK; Campo E; Braziel RM; Jaffe ES; Pan ZG; Farinha P; Smith LM; Falini B; Banham AH; Rosenwald A; Staudt LM; Connors JM; Armitage JO; Chan WC Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray | 0 | 0.00 | 0 | 0.00 | 0 | |
| 38 | 1 | 68 | 14 2002 CLINICAL LYMPHOMA 3(1):49-55
Schenkein D Proteasome inhibitors in the treatment of B-cell malignancies | 0 | 0.00 | 8 | 2.67 | 0 | 0 |
| 39 | 1 | 68 | 138 2003 MOLECULAR AND CELLULAR BIOLOGY 23(23):8651-8667
Kolluri SK; Bruey-Sedano N; Cao XH; Lin BZ; Lin F; Han YH; Dawson MI; Zhang XK Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells | 0 | 0.00 | 0 | 0.00 | 0 | |
| 40 | 1 | 67 | 60 2003 ANTICANCER RESEARCH 23(2A):1139-1148
Martin-Subero JI; Gesk S; Harder L; Grote W; Siebert R Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 41 | 2 | 65 | 32 2002 NATURE GENETICS 32():474-479
Petricoin EF; Hackett JL; Lesko LJ; Puri RK; Gutman SI; Chumakov K; Woodcock J; Feigal DW; Zoon KC; Sistare FD Medical applications of microarray technologies: a regulatory science perspective | 0 | 0.00 | 16 | 5.33 | 0 | 0 |
| 42 | 1 | 64 | 27 2002 JOURNAL OF CLINICAL ONCOLOGY 20(7):1932-1941
Ramaswamy S; Golub TR DNA microarrays in clinical oncology | 5 | 1.67 | 47 | 15.67 | 1 | 4 |
| 43 | 1 | 63 | 74 2003 BLOOD 102(3):1042-1050
Tracey L; Villuendas R; Dotor AM; Spiteri I; Ortiz P; Garcia JF; Peralto JLR; Lawler M; Piris MA Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study | 0 | 0.00 | 0 | 0.00 | 0 | |
| 44 | 4 | 61 | 93 2003 CLINICAL AND LABORATORY HAEMATOLOGY 25(4):209-220
Levene AP; Morgan GJ; Davies FE The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies | 0 | 0.00 | 0 | 0.00 | 0 | |
| 45 | 1 | 61 | 139 2003 MOLECULAR CANCER THERAPEUTICS 2(3):317-332
Covell DG; Wallqvist A; Rabow AA; Thanki N Molecular classification of cancer: Unsupervised self-organizing map analysis of gene expression microarray data | 0 | 0.00 | 2 | 1.00 | 0 | |
| 46 | 1 | 58 | 44 2002 ONCOLOGY-NEW YORK 16(5):7-13
Anzick SL; Trent JM Role of genomics in identifying new targets for cancer therapy | 1 | 0.33 | 4 | 1.33 | 0 | 1 |
| 47 | 1 | 57 | 6 2002 ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 37():225-236
McLaughlin F; LaThangue N Tumor classification for tailored cancer therapy | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 48 | 1 | 57 | 165 2003 TRENDS IN GENETICS 19(11):649-659
Leung YF; Cavalieri D Fundamentals of cDNA microarray data analysis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 49 | 1 | 56 | 92 2003 CANCER TREATMENT REVIEWS 29(2):91-98
Raetz E; Perkins S; Davenport V; Cairo MS B large-cell lymphoma in children and adolescents | 0 | 0.00 | 0 | 0.00 | 0 | |
| 50 | 1 | 55 | 31 2002 MAYO CLINIC PROCEEDINGS 77(9):927-940
Tefferi A; Bolander ME; Ansell SM; Wieben ED; Spelsberg TC Primer on medical genomics Part III: Microarray experiments and data analysis | 1 | 0.33 | 7 | 2.33 | 1 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 51 | 1 | 55 | 46 2002 PHARMACOGENOMICS 3(3):403-415
Ringner M; Peterson C; Khan J Analyzing array data using supervised methods | 1 | 0.33 | 5 | 1.67 | 0 | 1 |
| 52 | 1 | 55 | 52 2002 TRENDS IN MOLECULAR MEDICINE 8(6):288-293
Negm RS; Verma M; Srivastava S The promise of biomarkers in cancer screening and detection | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| 53 | 1 | 54 | 96 2003 CURRENT OPINION IN GENETICS & DEVELOPMENT 13(1):90-96
Lee S; Schmitt CA Chemotherapy response and resistance | 0 | 0.00 | 0 | 0.00 | 0 | |
| 54 | 1 | 54 | 157 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(5):2639-2644
Klein U; Tu YH; Stolovitzky GA; Keller JL; Haddad J; Miljkovic V; Cattoretti G; Califano A; Dalla-Favera R Transcriptional analysis of the B cell germinal center reaction | 1 | 0.50 | 6 | 3.00 | 1 | |
| 55 | 1 | 54 | 168 2004 BRITISH JOURNAL OF CANCER 90(1):216-223
Takenawa H; Kurosaki M; Enomoto N; Miyasaka Y; Kanazawa N; Sakamoto N; Ikeda T; Izumi N; Sato C; Watanabe M Differential gene-expression profiles associated with gastric adenoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 56 | 1 | 53 | 71 2003 BLOOD 101(3):1128-1140
Zhan FH; Tian EM; Bumm K; Smith R; Barlogie B; Shaughnessy J Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development | 3 | 1.50 | 11 | 5.50 | 3 | |
| 57 | 1 | 51 | 41 2002 NEPHRON 92(3):522-528
Cohen CD; Kretzler M Gene expression analysis in microdissected renal tissue - Current challenges and strategies | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 58 | 1 | 51 | 57 2003 ANNALS OF HEMATOLOGY 82(6):323-332
Schwaenen C; Wessendorf S; Kestler HA; Dohner H; Lichter P; Bentz M DNA microarray analysis in malignant lymphomas | 0 | 0.00 | 1 | 0.50 | 0 | |
| 59 | 2 | 50 | 35 2002 NATURE GENETICS 32():533-540
Chung CH; Bernard PS; Perou CM Molecular portraits and the family tree of cancer | 3 | 1.00 | 22 | 7.33 | 1 | 2 |
| 60 | 1 | 50 | 72 2003 BLOOD 101(7):2789-2796
Nishikori M; Maesako Y; Ueda C; Kurata M; Uchiyama T; Ohno H High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease | 0 | 0.00 | 3 | 1.50 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 61 | 1 | 50 | 84 2003 CANCER 97(11):2767-2775
Bono P; Teerenhovi L; Joensuu H Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 62 | 1 | 50 | 88 2003 CANCER CELL 3(2):173-183
Armstrong SA; Kung AL; Mabon ME; Silverman LB; Stam RW; Den Boer ML; Pieters R; Kersey JH; Sallan SE; Fletcher JA; Golub TR; Griffin JD; Korsmeyer SJ Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification | 2 | 1.00 | 19 | 9.50 | 2 | |
| 63 | 1 | 50 | 100 2003 DIAGNOSTIC MOLECULAR PATHOLOGY 12(1):35-43
de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV | 1 | 0.50 | 5 | 2.50 | 1 | |
| 64 | 1 | 49 | 51 2002 TRENDS IN MOLECULAR MEDICINE 8(6):269-272
Bustin SA; Dorudi S The value of microarray techniques for quantitative gene profiling in molecular diagnostics | 0 | 0.00 | 9 | 3.00 | 0 | 0 |
| 65 | 1 | 48 | 25 2002 INTERNATIONAL JOURNAL OF HEMATOLOGY 76():59-64
Shaughnessy JD; Barlogie B Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myeloma | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 66 | 1 | 48 | 36 2002 NATURE IMMUNOLOGY 3(8):780-786
Su TT; Guo BC; Kawakami Y; Sommer K; Chae K; Humphries LA; Kato RM; Kang S; Patrone L; Wall R; Teitell M; Leitges M; Kawakami T; Rawlings DJ PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling | 2 | 0.67 | 33 | 11.00 | 0 | 2 |
| 67 | 1 | 48 | 69 2003 BLOOD 101(1):78-84
Colomo L; Lopez-Guillermo A; Perales M; Rives S; Martinez A; Bosch F; Colomer D; Falini B; Montserrat E; Campo E Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma | 1 | 0.50 | 3 | 1.50 | 1 | |
| 68 | 1 | 48 | 94 2003 CLINICAL CANCER RESEARCH 9(16):5866-5873
Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model | 0 | 0.00 | 1 | 0.50 | 0 | |
| 69 | 1 | 48 | 102 2003 EXPERIMENTAL AND MOLECULAR PATHOLOGY 74(2):129-139
Patrone L; Henson SE; Teodorovic J; Malone CS; French SW; Wall R; Teitell MA Gene expression, patterns in AIDS versus non-AIDS-related diffuse large B-cell lymphoma | 0 | 0.00 | 1 | 0.50 | 0 | |
| 70 | 1 | 47 | 21 2002 CURRENT PHARMACEUTICAL DESIGN 8(25):2243-2248
Crump M Inhibition of raf kinase in the treatment of acute myeloid leukemia | 0 | 0.00 | 2 | 0.67 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 71 | 1 | 47 | 79 2003 BONE MARROW TRANSPLANTATION 32(7):673-679
Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 72 | 1 | 47 | 86 2003 CANCER 98(5):983-992
Cuttica A; Zallio F; Ladetto M; Di Nicola M; Caracciolo D; Magni M; Marinone C; Dell'Aquila M; Rosace M; Pileri A; Baccadoro M; Gianni AM; Tarella C Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting | 0 | 0.00 | 0 | 0.00 | 0 | |
| 73 | 1 | 46 | 2 2002 AMERICAN JOURNAL OF PATHOLOGY 161(2):413-420
Martin-Subero JI; Chudoba I; Harder L; Gesk S; Grote W; Novo FJ; Calasanz MJ; Siebert R Multicolor-FICTION - Expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses | 0 | 0.00 | 6 | 2.00 | 0 | 0 |
| 74 | 1 | 46 | 45 2002 PHARMACOGENOMICS 3(3):281-285
Jung V Fast forwarding pharmacogenomics | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 75 | 0 | 45 | 38 2002 NATURE MEDICINE 8(1):68-74
Shipp MA; Ross KN; Tamayo P; Weng AP; Kutok JL; Aguiar RCT; Gaasenbeek M; Angelo M; Reich M; Pinkus GS; Ray TS; Koval MA; Last KW; Norton A; Lister TA; Mesirov J; Neuberg DS; Lander ES; Aster JC; Golub TR Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning | 169 | 56.33 | 169 | 56.33 | 51 | 118 |
| 76 | 1 | 45 | 144 2003 NATURE MEDICINE 9(4):416-423
Ye QH; Qin LX; Forgues M; He P; Kim JW; Peng AC; Simon R; Li Y; Robles AI; Chen YD; Ma ZC; Wu ZQ; Ye SL; Liu YK; Tang ZY; Wang XW Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning | 0 | 0.00 | 5 | 2.50 | 0 | |
| 77 | 1 | 44 | 110 2003 HUMAN MOLECULAR GENETICS 12(8):823-836
Romualdi C; Campanaro S; Campagna D; Celegato B; Cannata N; Toppo S; Valle G; Lanfranchi G Pattern recognition in gene expression profiling using DNA array: a comparative study of different statistical methods applied to cancer classification | 0 | 0.00 | 0 | 0.00 | 0 | |
| 78 | 2 | 44 | 116 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 77(4):321-329
Lossos IS; Levy R Diffuse large B-cell lymphoma: Insights gained from gene expression profiling | 0 | 0.00 | 0 | 0.00 | 0 | |
| 79 | 1 | 44 | 135 2003 LEUKEMIA & LYMPHOMA 44(6):1027-1035
Wang ES; O'Connor O; She YH; Zelenetz AD; Sirotnak FM; Moore MAS Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression | 0 | 0.00 | 1 | 0.50 | 0 | |
| 80 | 1 | 43 | 17 2002 CURRENT OPINION IN HEMATOLOGY 9(4):339-344
Armstrong SA; Hsieh JJD; Korsmeyer SJ Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 81 | 1 | 43 | 49 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(24):15536-15541
Tudor M; Akbarian S; Chen RZ; Jaenisch R Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain | 0 | 0.00 | 17 | 5.67 | 0 | 0 |
| 82 | 1 | 43 | 50 2002 TRENDS IN BIOTECHNOLOGY 20(12):S23-S29
Flory MR; Griffin TJ; Martin D; Aebersold R Advances in quantitative proteomics using stable isotope tags | 0 | 0.00 | 7 | 2.33 | 0 | 0 |
| 83 | 1 | 43 | 53 2003 AMERICAN JOURNAL OF CLINICAL PATHOLOGY 119(3):424-430
Weng AP; Shahsafaei A; Dorfman DM CXCR4/CD184 immunoreactivity in T-cell non-Hodgkin lymphomas with an overall Th1-Th2+immunophenotype | 0 | 0.00 | 1 | 0.50 | 0 | |
| 84 | 3 | 43 | 87 2003 CANCER BIOLOGY & THERAPY 2(3):242-247
Mischel PS; Nelson SF; Cloughesy TF Molecular analysis of glioblastoma - Pathway profiling and its implications for patient therapy | 0 | 0.00 | 0 | 0.00 | 0 | |
| 85 | 1 | 42 | 15 2002 CROATIAN MEDICAL JOURNAL 43(5):519-525
Kusec R Molecular and genetic mechanisms of lymphomagenesis | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 86 | 1 | 41 | 3 2002 AMERICAN JOURNAL OF PATHOLOGY 161(4):1223-1233
Ginestier C; Charafe-Jauffret E; Bertucci F; Eisinger F; Geneix J; Bechlian D; Conte N; Adelaide J; Toiron Y; Nguyen C; Viens P; Mozziconacci MJ; Houlgatte R; Birnbaum D; Jacquemier J Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers | 1 | 0.33 | 8 | 2.67 | 0 | 1 |
| 87 | 2 | 41 | 137 2003 MAYO CLINIC PROCEEDINGS 78(9):1098-1109
Shaughnessy J Primer on medical genomics - Part IX: Scientific and clinical applications of DNA microarrays - Multiple myeloma as a disease model | 0 | 0.00 | 0 | 0.00 | 0 | |
| 88 | 4 | 40 | 62 2003 BIOCHEMICAL SOCIETY TRANSACTIONS 31():1497-1502
Soinov LA Supervised classification for gene network reconstruction | 0 | 0.00 | 0 | 0.00 | 0 | |
| 89 | 2 | 40 | 148 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(18):1777-1785
Staudt LM Molecular diagnosis of the hematologic cancers | 2 | 1.00 | 7 | 3.50 | 2 | |
| 90 | 1 | 37 | 10 2002 CANCER CELL 2(5):363-366
Staudt LM; Wilson WH Focus on lymphomas | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 91 | 1 | 37 | 11 2002 CLINICAL CARDIOLOGY 25(11):I9-I15
Topol EJ Economics and quality of care for patients with acute coronary syndromes: The impending crisis | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 92 | 1 | 37 | 75 2003 BLOOD 102(5):1849-1856
Yagi T; Morimoto A; Eguchi M; Hibi S; Sako M; Ishii E; Mizutani S; Imashuku S; Ohki M; Ichikawa H Identification of a gene expression signature associated with pediatric AML prognosis | 0 | 0.00 | 4 | 2.00 | 0 | |
| 93 | 1 | 37 | 95 2003 CURRENT OPINION IN CELL BIOLOGY 15(2):213-220
Ciro M; Bracken AP; Helin K Profiling cancer | 0 | 0.00 | 1 | 0.50 | 0 | |
| 94 | 2 | 37 | 97 2003 CURRENT OPINION IN GENETICS & DEVELOPMENT 13(1):97-103
Liu ET Classification of cancers by expression profiling | 0 | 0.00 | 2 | 1.00 | 0 | |
| 95 | 3 | 37 | 104 2003 GENES CHROMOSOMES & CANCER 38(3):207-214
Lu YJ; Williamson D; Wang R; Summersgill B; Rodriguez S; Rogers S; Pritchard-Jones K; Campbell C; Shipley J Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior | 0 | 0.00 | 0 | 0.00 | 0 | |
| 96 | 1 | 37 | 121 2003 JOURNAL OF COMPUTATIONAL BIOLOGY 10(2):119-142
Mukherjee S; Tamayo P; Rogers S; Rifkin R; Engle A; Campbell C; Golub TR; Mesirov JP Estimating dataset size requirements for classifying DNA microarray data | 2 | 1.00 | 2 | 1.00 | 2 | |
| 97 | 1 | 37 | 152 2003 ONCOGENE 22(31):4918-4923
Shai R; Shi T; Kremen TJ; Horvath S; Liau LM; Cloughesy TF; Mischel PS; Nelson SF Gene expression profiling identifies molecular subtypes of gliomas | 0 | 0.00 | 2 | 1.00 | 0 | |
| 98 | 1 | 37 | 166 2003 TRENDS IN MOLECULAR MEDICINE 9(1):5-10
Hampton GM; Frierson HF Classifying human cancer by analysis of gene expression | 0 | 0.00 | 1 | 0.50 | 0 | |
| 99 | 1 | 36 | 9 2002 CANCER CELL 2(5):353-361
Miller LD; Long PM; Wong L; Mukherjee S; McShane LM; Liu ET Optimal gene expression analysis by microarrays | 1 | 0.33 | 9 | 3.00 | 0 | 1 |
| 100 | 1 | 36 | 20 2002 CURRENT OPINION IN PHARMACOLOGY 2(5):551-554
Crowther DJ Applications of microarrays in the pharmaceutical industry | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 101 | 1 | 36 | 83 2003 BRITISH JOURNAL OF HAEMATOLOGY 123(4):621-630
Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 102 | 4 | 36 | 99 2003 CURRENT OPINION IN STRUCTURAL BIOLOGY 13(3):370-376
Stolovitzky G Gene selection in microarray data: the elephant, the blind men and our algorithms | 1 | 0.50 | 1 | 0.50 | 1 | |
| 103 | 1 | 35 | 66 2003 BIOTECHNIQUES ():22-+
Scharpf R; Garrett ES; Hu J; Parmigiani G Statistical modeling and visualization of molecular profiles in cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 104 | 1 | 35 | 70 2003 BLOOD 101(2):433-440
Lossos IS; Alizadeh AA; Rajapaksa R; Tibshirani R; Levy R HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma | 1 | 0.50 | 3 | 1.50 | 1 | |
| 105 | 1 | 35 | 101 2003 EUROPEAN JOURNAL OF IMMUNOLOGY 33(1):1-11
Kondo E; Harashima A; Takabatake T; Takahashi H; Matsuo Y; Yoshino T; Orita K; Akagi T NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor | 0 | 0.00 | 0 | 0.00 | 0 | |
| 106 | 1 | 34 | 48 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(13):8778-8783
Birrell GW; Brown JA; Wu HI; Giaever G; Chu AM; Davis RW; Brown JM Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents | 0 | 0.00 | 20 | 6.67 | 0 | 0 |
| 107 | 1 | 34 | 106 2003 GENOME BIOLOGY 4(12):-
Yeung KY; Bumgarner RE Multiclass classification of microarray data with repeated measurements: application to cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 108 | 1 | 34 | 124 2003 JOURNAL OF NEPHROLOGY 16(4):597-602
Carella M; Volinia S; Gasparini P Nanotechnologies and microchips in genetic diseases | 0 | 0.00 | 0 | 0.00 | 0 | |
| 109 | 1 | 33 | 59 2003 ANNALS OF SURGICAL ONCOLOGY 10(1):7-14
Yeatman TJ The future of cancer management: Translating the genome, transcriptome, and proteome | 0 | 0.00 | 3 | 1.50 | 0 | |
| 110 | 1 | 33 | 90 2003 CANCER SCIENCE 94(9):774-781
Maesako Y; Uchiyama T; Ohno H Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 111 | 3 | 33 | 120 2003 JOURNAL OF CLINICAL PATHOLOGY 56(10):747-752
Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases | 0 | 0.00 | 0 | 0.00 | 0 | |
| 112 | 2 | 33 | 123 2003 JOURNAL OF MOLECULAR DIAGNOSTICS 5(2):113-120
Wang ZY; Zhang Q; Wilson J; Ratajczak MZ; Wasik MA Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific polymerase chain reaction and parallel denaturing gradient gel electrophoresis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 113 | 1 | 32 | 76 2003 BLOOD 102(6):1989-1996
Hamlin PA; Zelenetz AD; Kewalramani T; Qin J; Satagopan JM; Verbel D; Noy A; Portlock CS; Straus DJ; Yahalom J; Nimer SD; Moskowitz CH Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 114 | 1 | 32 | 80 2003 BREAST CANCER RESEARCH AND TREATMENT 82(2):113-123
Assersohn L; Salter J; Powles TJ; A'hern R; Makris A; Gregory RK; Chang J; Dowsett M Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 115 | 1 | 32 | 105 2003 GENOME BIOLOGY 4(3):-
Muro S; Takemasa I; Oba S; Matoba R; Ueno N; Maruyama C; Yamashita R; Sekimoto M; Yamamoto H; Nakamori S; Monden M; Ishii S; Kato K Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data | 0 | 0.00 | 2 | 1.00 | 0 | |
| 116 | 1 | 32 | 107 2003 GENOME RESEARCH 13(3):467-475
Kajiyama T; Miyahara Y; Kricka LJ; Wilding P; Graves DJ; Surrey S; Fortina P Genotyping on a thermal gradient DNA chip | 0 | 0.00 | 2 | 1.00 | 0 | |
| 117 | 1 | 31 | 63 2003 BIOINFORMATICS 19(1):45-52
Deutsch JM Evolutionary algorithms for finding optimal gene sets in microarray prediction | 3 | 1.50 | 4 | 2.00 | 3 | |
| 118 | 2 | 31 | 67 2003 BIOTECHNIQUES ():30-+
Ringner M; Peterson C Microarray-based cancer diagnosis with artificial neural networks | 0 | 0.00 | 0 | 0.00 | 0 | |
| 119 | 2 | 31 | 155 2003 PHARMACOGENOMICS 4(2):179-189
Nawrocki S; Skacel T; Brodowicz T From microarrays to new therapeutic approaches in bladder cancer | 0 | 0.00 | 1 | 0.50 | 0 | |
| 120 | 1 | 30 | 85 2003 CANCER 98(3):516-521
Moller MB; Christensen BE; Pedersen NT Prognosis of localized diffuse large B-Cell lymphoma in younger patients - Predictive value of age-and stage-adjustment of the international prognostic index | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 121 | 1 | 30 | 125 2003 JOURNAL OF PATHOLOGY 199(2):201-207
Tzankov A; Zimpfer A; Lugli A; Krugmann J; Went P; Schraml P; Maurer R; Ascani S; Pileri S; Geley S; Dimhofer S High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1 | 1 | 0.50 | 4 | 2.00 | 1 | |
| 122 | 2 | 30 | 151 2003 ONCOGENE 22(20):3076-3080
Carr KM; Bittner M; Trent JM Gene-expression profiling in human cutaneous melanoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 123 | 1 | 29 | 54 2003 AMERICAN JOURNAL OF HEMATOLOGY 73(4):230-235
Seki R; Okamura T; Koga H; Yakushiji K; Hashiguchi M; Yoshimoto K; Ogata H; Imamura R; Nakashima Y; Kage M; Ueno T; Sata M Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 124 | 1 | 29 | 108 2003 HISTOPATHOLOGY 43(3):209-219
Zettl A; Meister S; Katzenberger T; Kalla J; Ott MM; Muller-Hermelink HK; Ott G Immunohistochemical analysis of B-cell lymphoma using tissue microarrays identifies particular phenotypic profiles of B-cell lymphomas | 0 | 0.00 | 0 | 0.00 | 0 | |
| 125 | 1 | 29 | 133 2003 LEUKEMIA 17(9):1880-1890
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CIE; Sander B High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 126 | 1 | 29 | 141 2003 NATURE GENETICS 33(1):49-54
Ramaswamy S; Ross KN; Lander ES; Golub TR A molecular signature of metastasis in primary solid tumors | 3 | 1.50 | 50 | 25.00 | 3 | |
| 127 | 1 | 28 | 89 2003 CANCER RESEARCH 63(16):5159-5164
Ishibashi Y; Hanyu N; Nakada K; Suzuki Y; Yamamoto T; Yanaga K; Ohkawa K; Hashimoto N; Nakajima T; Saito H; Matsushima M; Urashima M Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 128 | 3 | 27 | 156 2003 PHARMACOGENOMICS JOURNAL 3(5):257-260
Covitz PA Class struggle: expression profiling and categorizing cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 129 | 1 | 27 | 158 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(14):8418-8423
Sorlie T; Tibshirani R; Parker J; Hastie T; Marron JS; Nobel A; Deng S; Johnsen H; Pesich R; Geisler S; Demeter J; Perou CM; Lonning PE; Brown PO; Borresen-Dale AL; Botstein D Repeated observation of breast tumor subtypes in independent gene expression data sets | 0 | 0.00 | 5 | 2.50 | 0 | |
| 130 | 1 | 26 | 26 2002 JAPANESE JOURNAL OF CANCER RESEARCH 93(11):1207-1212
Ando T; Suguro M; Hanai T; Kobayashi T; Honda H; Seto M Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma | 2 | 0.67 | 3 | 1.00 | 0 | 2 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 131 | 1 | 26 | 55 2003 AMERICAN JOURNAL OF HEMATOLOGY 74(2):94-98
Moller MB; Pedersen NT; Christensen BE Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 132 | 3 | 26 | 81 2003 BRITISH JOURNAL OF CANCER 89(9):1599-1604
Simon R Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data | 0 | 0.00 | 0 | 0.00 | 0 | |
| 133 | 1 | 26 | 142 2003 NATURE GENETICS 33(1):90-96
Dyrskjot L; Thykjaer T; Kruhoffer M; Jensen JL; Marcussen N; Hamilton-Dutoit S; Wolf H; Orntoft TF Identifying distinct classes of bladder carcinoma using microarrays | 1 | 0.50 | 14 | 7.00 | 1 | |
| 134 | 1 | 25 | 128 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(8):598-605
Gordon GJ; Jensen RV; Hsiao LL; Gullans SR; Blumenstock JE; Richards WG; Jaklitsch MT; Sugarbaker DJ; Bueno R Using gene expression ratios to predict outcome among patients with mesothelioma | 0 | 0.00 | 1 | 0.50 | 0 | |
| 135 | 2 | 25 | 129 2003 JOURNAL OF UROLOGY 170(6):S11-S19
Febbo PG; Sellers WR Use of expression analysis to predict outcome after radical prostatectomy | 0 | 0.00 | 0 | 0.00 | 0 | |
| 136 | 1 | 25 | 132 2003 LEUKEMIA 17(4):789-795
Lossos IS; Czerwinski DK; Wechser MA; Levy R Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies | 0 | 0.00 | 1 | 0.50 | 0 | |
| 137 | 1 | 24 | 170 2004 LEUKEMIA & LYMPHOMA 45(1):101-107
Maartense E; Kramer MHH; Le Cessie S; Kluin-Nelemans JC; Kluin PM; Snijder S; Noordijk EM Lack of prognostic significance of BCL2 and p53 protein overexpression in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma: Results from a population-based non-Hodgkin's lymphoma registry | 0 | 0.00 | 0 | 0.00 | 0 | |
| 138 | 1 | 23 | 7 2002 BULLETIN DU CANCER 89(7-8):661-665
Bertucci F; Salas S; Nasser V; Birnbaum D; Xerri L Prognostic value of gene expression profiling using cDNA arrays in lymphomas | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| 139 | 1 | 23 | 16 2002 CURRENT OPINION IN HEMATOLOGY 9(4):333-338
Davis RE; Staudt LM Molecular diagnosis of lymphoid malignancies by gene expression profiling | 2 | 0.67 | 11 | 3.67 | 1 | 1 |
| 140 | 1 | 23 | 18 2002 CURRENT OPINION IN ONCOLOGY 14(4):406-411
Schofield D; Triche TJ cDNA microarray analysis of global gene expression in sarcomas | 0 | 0.00 | 3 | 1.00 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 141 | 3 | 23 | 91 2003 CANCER SCIENCE 94(10):906-913
Ando T; Suguro M; Kobayashi T; Seto M; Honda H Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling | 0 | 0.00 | 0 | 0.00 | 0 | |
| 142 | 1 | 22 | 64 2003 BIOINFORMATICS 19(13):1620-1627
Pavlidis P; Li QH; Noble WS The effect of replication on gene expression microarray experiments | 0 | 0.00 | 0 | 0.00 | 0 | |
| 143 | 1 | 22 | 65 2003 BIOINFORMATICS 19(16):2088-2096
Oba S; Sato M; Takemasa I; Monden M; Matsubara K; Ishii S A Bayesian missing value estimation method for gene expression profile data | 0 | 0.00 | 0 | 0.00 | 0 | |
| 144 | 1 | 22 | 73 2003 BLOOD 102(1):297-302
Shi B; Hsu HL; Evens AM; Gordon LI; Gartenhaus RB Expression of the candidate MCT-1 oncogene in B-and T-cell lymphoid malignancies | 0 | 0.00 | 0 | 0.00 | 0 | |
| 145 | 1 | 22 | 127 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(1):14-18
Simon R; Radmacher MD; Dobbin K; McShane LM Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification | 4 | 2.00 | 16 | 8.00 | 4 | |
| 146 | 1 | 21 | 126 2003 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 86(3-5):301-307
Ellis MJ; Rosen E; Dressman H; Marks J Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect | 0 | 0.00 | 0 | 0.00 | 0 | |
| 147 | 1 | 20 | 56 2003 AMERICAN SURGEON 69(1):41-44
Yeatman TJ The future of clinical cancer management: One tumor, one chip | 0 | 0.00 | 4 | 2.00 | 0 | |
| 148 | 1 | 20 | 68 2003 BIOTECHNIQUES ():55-61
Draghici S; Khatri P; Shah A; Tainsky MA Assessing the functional bias of commercial microarrays using the onto-compare database | 0 | 0.00 | 0 | 0.00 | 0 | |
| 149 | 2 | 20 | 118 2003 JOURNAL OF BIOSCIENCE AND BIOENGINEERING 96(2):161-167
Ando T; Suguro M; Kobayashi T; Seto M; Honda H Selection of causal gene sets for lymphoma prognostication from expression profiling and construction of prognostic fuzzy neural network models | 1 | 0.50 | 1 | 0.50 | 1 | |
| 150 | 1 | 19 | 61 2003 ARTIFICIAL INTELLIGENCE REVIEW 20(1-2):39-51
Karzynski M; Mateos A; Herrero J; Dopazo J Using a genetic algorithm and a perceptron for feature selection and supervised class learning in DNA microarray data | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 151 | 1 | 19 | 82 2003 BRITISH JOURNAL OF CANCER 89(12):2284-2288
Leonard P; Sharp T; Henderson S; Hewitt D; Pringle J; Sandison A; Goodship A; Whelan J; Boshoff C Gene expression array profile of human osteosarcoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 152 | 1 | 18 | 149 2003 NEW TRENDS IN CANCER FOR THE 21ST CENTURY 532():223-234
Ellis MJ Breast cancer gene expression analysis - The case for dynamic profiling | 0 | 0.00 | 0 | 0.00 | 0 | |
| 153 | 2 | 18 | 160 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(19):10585-10587
Ferl GZ; Timmerman JM; Witte ON Extending the utility of gene profiling data by bridging microarray platforms | 0 | 0.00 | 0 | 0.00 | 0 | |
| 154 | 1 | 15 | 114 2003 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 35(2):119-124
Schmidt U; Begley CG Cancer diagnosis and microarrays | 0 | 0.00 | 0 | 0.00 | 0 | |
| 155 | 1 | 15 | 119 2003 JOURNAL OF CLINICAL PATHOLOGY 56(2):159-159
Pileri SA; Sabattini E; Ascani S; Zinzani PL; Falini B How do we define Hodgkin's disease? The authors' reply | 0 | 0.00 | 0 | 0.00 | 0 | |
| 156 | 1 | 15 | 159 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(17):9991-9996
Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma | 3 | 1.50 | 4 | 2.00 | 3 | |
| 157 | 1 | 14 | 143 2003 NATURE GENETICS 34(2):226-230
Huang E; Ishida S; Pittman J; Dressman H; Bild A; Kloos M; D'Amico M; Pestell RG; West M; Nevins JR Gene expression phenotypic models that predict the activity of oncogenic pathways | 0 | 0.00 | 4 | 2.00 | 0 | |
| 158 | 1 | 13 | 13 2002 CLINICAL LYMPHOMA 2(4):200-201
Armitage JO Follicular lymphoma | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 159 | 2 | 13 | 122 2003 JOURNAL OF INVESTIGATIVE DERMATOLOGY 120(5):VII-VIII
Dummer R; Urosevic M; Hoek K; Haffner A; Burg G Exploring primary cutaneous B-cell lymphoma by microarray technology | 0 | 0.00 | 0 | 0.00 | 0 | |
| 160 | 1 | 12 | 42 2002 NEW ENGLAND JOURNAL OF MEDICINE 346(25):1998-1999
Magrath I Molecular characteristics of diffuse large-B-cell lymphoma | 1 | 0.33 | 2 | 0.67 | 1 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 161 | 1 | 12 | 78 2003 BMC BIOINFORMATICS 4():-
O'Neill MC; Song L Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect | 0 | 0.00 | 0 | 0.00 | 0 | |
| 162 | 1 | 12 | 109 2003 HUMAN MOLECULAR GENETICS 12():R153-R157
Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction | 0 | 0.00 | 0 | 0.00 | 0 | |
| 163 | 1 | 9 | 37 2002 NATURE MEDICINE 8(1):13-14
Van't Veer LJ; De Jong D The microarray way to tailored cancer treatment | 0 | 0.00 | 11 | 3.67 | 0 | 0 |
| 164 | 1 | 9 | 140 2003 NATURE 424(6949):610-612
Tilstone C Vital statistics | 0 | 0.00 | 0 | 0.00 | 0 | |
| 165 | 1 | 8 | 5 2002 ANNALS OF ONCOLOGY 13(3):339-341
[Anon] Perhaps not everyone knows that ... | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 166 | 1 | 8 | 29 2002 LEUKEMIA 16(11):2326-2329
Thieblemont C; Chettab K; Felman P; Callet-Bauchu E; Traverse-Glehen A; Berger F; Dumontet C; Cerutti C; Baseggio L; Salles G; Paultre C; Coiffier B; McGregor JL Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis | 1 | 0.33 | 4 | 1.33 | 0 | 1 |
| 167 | 1 | 8 | 43 2002 ONCOLOGY-NEW YORK 16(4):511-512
Greer JP The Armitage article reviewed | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 168 | 1 | 6 | 30 2002 LEUKEMIA 16(12):2457-2458
Kussick SJ; Wood BL; Sabath DE Mature T cell leukemias which cannot be adequately classified under the new WHO classification of lymphoid neoplasms | 0 | 0.00 | 3 | 1.00 | 0 | 0 |
| 169 | 2 | 5 | 4 2002 ANNALES DE PATHOLOGIE 22():S84-S85
Gilles F Cell biopsy and gene expression profile | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 170 | 1 | 4 | 8 2002 CANCER BIOLOGY & THERAPY 1(4):436-437
El-Deiry WS Phenomenology and scientific progress | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
Generated by: HistCite(Vlad).
Version: 2004.01.07